TRVI (Trevi Therapeutics, Inc.) operates in the Health technology sector. It's currently trading at $19.61. Our composite momentum score rates it 77/110 based on price +6.3% (1d) — solid move, rvol 2.2x — elevated volume, rsi 71.4 — overbought, roc9 +17.5% — sharp acceleration, macd 0.28 — bullish, beta 2.02 — high beta, and analyst: strong buy. Up 19.8% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.